These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34496148)

  • 21. Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya.
    Omollo V; Roche SD; Mogaka F; Odoyo J; Barnabee G; Bukusi EA; Katz AWK; Morton J; Johnson R; Baeten JM; Celum C; O'Malley G
    Sex Reprod Health Matters; 2022 Dec; 30(1):2095707. PubMed ID: 36169648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using FRAME to characterize provider-identified adaptations to a stepped care intervention for adolescents and youth living with HIV in Kenya: a mixed methods approach.
    Chhun N; Oketch D; Agot K; Mangale DI; Badia J; Kibugi J; Jiang W; Kirk M; Richardson BA; Kohler PK; John-Stewart G; Beima-Sofie K
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26261. PubMed ID: 38965971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
    Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
    J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
    Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya.
    Pintye J; Rogers Z; Kinuthia J; Mugwanya KK; Abuna F; Lagat H; Sila J; Kemunto V; Baeten JM; John-Stewart G; Unger JA
    Glob Health Sci Pract; 2020 Mar; 8(1):55-67. PubMed ID: 32139420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief Report: Integration of PrEP Services Into Routine Antenatal and Postnatal Care: Experiences From an Implementation Program in Western Kenya.
    Pintye J; Kinuthia J; Roberts DA; Wagner AD; Mugwanya K; Abuna F; Lagat H; Owiti G; Levin CE; Barnabas RV; Baeten JM; John-Stewart G
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):590-595. PubMed ID: 30204720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
    Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
    Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
    Nakambale HN; Roche SD; Mogere P; Omollo V; Kuo AP; Stergachis A; Baeten JM; Bukusi E; Ngure K; Mugambi ML; Ortblad KF
    Front Reprod Health; 2023; 5():1023568. PubMed ID: 36895656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
    Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
    J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Self-Testing for Efficient PrEP Delivery Is Highly Acceptable and Feasible in Public Health HIV Clinics in Kenya: A Mixed Methods Study.
    Ogello V; Ngure K; Mwangi P; Owidi E; Wairimu N; Etyang L; Mwangi M; Mwangi D; Maina S; Mugo N; Mugwanya K
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241274311. PubMed ID: 39155573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial.
    Ngure K; Ortblad KF; Mogere P; Bardon AR; Thomas KK; Mangale D; Kiptinness C; Gakuo S; Mbaire S; Nyokabi J; Mugo NR; Baeten JM
    Lancet HIV; 2022 Jul; 9(7):e464-e473. PubMed ID: 35777410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.
    Roche SD; Wairimu N; Mogere P; Kamolloh K; Odoyo J; Kwena ZA; Bukusi EA; Ngure K; Baeten JM; Ortblad KF
    AIDS Behav; 2021 Dec; 25(12):3871-3882. PubMed ID: 33826022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya.
    Wanga V; Peebles K; Obiero A; Mogaka F; Omollo V; Odoyo JB; Morton JF; Bukusi EA; Celum C; Baeten JM; Barnabas RV
    PLoS One; 2021; 16(4):e0249625. PubMed ID: 33857195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Models of HIV Pre-Exposure Prophylaxis Care Used in Title X Family Planning Clinics in the Southern U.S.
    Piper KN; Escoffery C; Sales JM; Sheth AN
    J Adolesc Health; 2021 Mar; 68(3):480-487. PubMed ID: 33160826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating HIV Pre-Exposure Prophylaxis into Family Planning Care: A RE-AIM Framework Evaluation.
    Brant AR; Dhillon P; Hull S; Coleman M; Ye PP; Lotke PS; Folan J; Scott RK
    AIDS Patient Care STDS; 2020 Jun; 34(6):259-266. PubMed ID: 32484743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PrEP distribution in pharmacies: a systematic review.
    Kennedy CE; Yeh PT; Atkins K; Ferguson L; Baggaley R; Narasimhan M
    BMJ Open; 2022 Feb; 12(2):e054121. PubMed ID: 35190430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.